Updated Jul 16, 2026
Taylor Brenton has filed 1 SEC Form 4 filing across 1 company in the last 90 days — selling. Lifetime open-market sales: $134K.
Brenton Taylor is an executive at Sight Sciences, Inc., where he has held various roles including EVP of Operations and R&D. He is involved in the development and commercialization of ophthalmic medical devices.
| Role | Insider |
|---|---|
| Notability | 20/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-07-06 | SGHT | Sight Sciences, Inc. | S — Open-market sale | 2.8K | $5.42 | $15K |
| 2026-04-03 | SGHT | Sight Sciences, Inc. | S — Open-market sale | 2.9K | $3.70 | $11K |
| 2026-02-05 | SGHT | Sight Sciences, Inc. | A — Grant or award | 100.5K | $0.00 | |
| 2026-01-07 | SGHT | Sight Sciences, Inc. | S — Open-market sale | 619 | $7.48 | $5K |
| 2025-11-18 | SGHT | Sight Sciences, Inc. | S — Open-market sale | 14.4K | $7.06 | $102K |
| 2025-10-06 | SGHT | Sight Sciences, Inc. | S — Open-market sale | 591 | $3.37 | $2K |
| 2025-09-02 | SGHT | Sight Sciences, Inc. | A — Grant or award | 25.8K | $0.00 | |
| 2024-11-18 | SGHT | Sight Sciences, Inc. | A — Grant or award | 160.0K | $4.59 | $734K |
Brenton Taylor is an executive at Sight Sciences, Inc., where he has held various roles including EVP of Operations and R&D. He is involved in the development and commercialization of ophthalmic medical devices.…
1 primary Form 4 filings in the last 90 days, covering 1 company.
Recorded transactions: 0 open-market purchases () and 5 open-market sales ($134K) across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Taylor Brenton profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.